Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.

Article Details

Citation

Copy to clipboard

Davis KL

Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.

Geriatrics. 1999 Feb;54(2):42-7; quiz 48.

PubMed ID

10024872 [ View in PubMed

]

Abstract

Alzheimer's disease (AD) is characterized in the brain by the deposition of amyloid protein outside the neuron, resulting in the formation of plaques, and inside the neuron with neurofibrillary tangles. It is not yet known what causes these pathologic changes, although age and genetics are major risk factors. The cholinesterase inhibitors tacrine and donepezil block acetylcholinesterase and therefore preserve the neurotransmitter acetylcholine. Three other investigational cholinesterase inhibitors are rivastigmine, metrifonate, and galanthamine. Existing therapies being studied for use in AD include vitamin E, estrogen preparations, and anti-inflammatory agents. The physician's role is to care for both the AD patient and the family, which are profoundly affected by this disease.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Donepezil	Acetylcholinesterase	Protein	Humans	Yes	Inhibitor	Details
Tacrine	Acetylcholinesterase	Protein	Humans	Yes	Inhibitor	Details